EZH2 and pancreatic neoplasm: Detailed mechanistic insights revealed that HOXA-AS2 interacted directly with EZH2 (enhancer of zeste homolog-2) and lysine specific demethylase 1 (LSD1) and synchronously promoted growth ability of pancreatic cancer cells (59).